Targeting Moieties
- Authors: Constantin V. Uglea1, Marcel Popa2
-
View Affiliations Hide Affiliations1 “Grigore T. Popa” University of Medicine and Pharmacy Iasi, Department of Medical Bioengineering, Universitatii Str., no. 16, 700115 Iasi, Romania 2 “Gheorghe Asachi” Technical University of Iasi, Faculty of Chemical Engineering and Environmental Protection, Department of Natural and Synthetic Polymers, Prof. dr. docent Dimitrie Mangeron Str., no. 73, 700050, Iasi, Romania
- Source: Polymeric Nanomedicines , pp 144-189
- Publication Date: May 2013
- Language: English
Preview this chapter:
Targeting Moieties, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781608054848/chapter-4-1.gif
This chapter summarizes the exploitation of drug loaded nanocarrier conjugates with various targeting moieties for the delivery and targeting of drugs and describes the current status of and challenges in the field of nanocarrier-aided drug delivery and drug targeting. The discovery of targeting ligands and the development of ligand targeted therapy will help us to improve therapeutic efficacy and reduce side effects. Unlike other forms of therapy, it will allow us to maintain quality of life for patients, while efficiently attacking diseased cells and indicates that ligands have a pivotal role especially in cancer cell targeting.
Hardbound ISBN:
9781608056286
Ebook ISBN:
9781608054848
-
From This Site
/content/books/9781608054848.chapter-4dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
/content/books/9781608054848.chapter-4
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9781608054848
Book
false
en
